28.7 C
March 5, 2024
Let Out  News
Image default
Editor's Picks National News

Government appeals to Ugandans to embrace clinical trials of local treatment for COVID-19

The Presidential Scientific Initiative on Epidemics (PRESIDE) has appealed to Ugandans to embrace the clinical trial of UBV-01N, a locally developed COVID-19 treatment regimen and volunteer in the tests as needed.

According to PRESIDE, (a think tank of scientists who were tasked to address multiple aspects of pandemics, covid-19 inclusive) the regimen has been proved safe and a trail will be performed as a measure to prove its efficacy against the Coronavirus and its variants.

PRESIDE has been holding scientific hackathons and engaging scientists in order to develop products in the areas of Vaccines, Therapeutics and Diagnostics that would help in the treatment of COVID-19 since the outbreak of the Covid-19 March last year.

A statement released on the 27th of January 2021 by the Presidential initiative reveals that at least 23 projects have so far been funded through PRESIDE and its through one of the 23 projects that this regimen was analyzed, validated, approved and certified by regulatory authorities in Uganda to go into the clinical trial phase.

The regimen was presented to PRESIDE by the Natural Chemotherapeutic Research Institute (NCRI) as a natural chemotherapeutic product that treats viral and bacterial infections in April last year.

During the hackathons, a literature that proved the scientific concept of the proposal and funding by PRESIDE was developed and presented.

PRESIDE officials noted in a statement that Dr. Grace Nambatya Kyeyune has been leading the rigorous process to come up with the product scientifically.

“Since April 2020, the NCRI researchers led by Dr. Grace Nambatya Kyeyune, have worked tirelessly through all the rigorous processes to come up with a scientifically proven product that is ready for clinical trials now. The government through the Ministry of Finance, provided funds that were channeled through the Ministry of Science, Technology and Innovation (MOSTI) to procure equipment and meet operational costs.”

President Museveni on Wednesday officiated the first clinical trial of what was termed as ‘a highly scientific process to analyse and validate a natural product anticipated to have antiviral (kill viruses), anti – inflammatory (reduces over reaction of the body to infections) and immunological (directs the immune system in the right direction) ability.

Dr. Grace Nambatya, says the clinical trial is meant to validate the content, standardise and replicate the product after which it will be rolled out for industrial reproduction. She says the product is safe and appealed to Ugandans to willingly participate and volunteer in the process when asked to.

“The product has already gone through multiple quality assurance steps and got all the necessary certifications and approval for use in human beings in a clinical trial setting,” she said.

The regimen has been given code UBV-01N since it’s the first natural chemotherapeutic product to go through an international level clinical trial process.

At this stage, the regimen has been approved by the National Drug Authority (NDA), the Uganda National Bureau of Standards (UNBS) and the National Council for Science and Technology.

Related posts

Soltilo Bright Stars shocks KCCA FC at Lugogo

Edwin Musaazi

Seals to voting materials in Hoima and Koboko tampered with

Giles Kirimwira

Shocking video shows Ugandan nursery kids doing sexual acts in class

Sigmund Ainembabazi

Leave a Reply

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

%d bloggers like this: